Huadong Medicine Co., Ltd
000963.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$47.86B
Close$
$69.30
164% upside
Current Fair Value
164% upsideUndervalued by 164% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $47.86 Billion |
|---|---|
| Enterprise Value | $47.69 Billion |
| Dividend Yield | $0.93 (3.41%) |
| Earnings per Share | $1.95 |
| Beta | 0.02 |
| Outstanding Shares | 1,753,736,848 |
Return
| Return on Equity | 13.60% |
|---|---|
| Return on Assets | 8.64% |
| Return on Invested Capital | 15.50% |
Valuation & Multiples
| P/E Ratio | 13.85 |
|---|---|
| PEG | -300.1 |
| Price to Sales | 1.05 |
| Price to Book Ratio | 1.88 |
| Enterprise Value to Revenue | 1.08 |
| Enterprise Value to EBIT | 11.55 |
| Enterprise Value to Net Income | 13 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.21 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
$0.56
Average shareholder expectationRevenue Estimate
$11.66 B
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$0.51
Average shareholder expectationRevenue Estimate
$11.29 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Huadong Medicine Co., Ltd
19,095 employees
CEO: Liang Lv Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses tradition...